Cho Pharma Inc. (6586)
TWSE
Closed
Aug 25, 2026
Day's Range
110.0052 wk Range
22.75Overview - 6586 - Cho Pharma Inc.
Key Statistics
Valuation
Enterprise Value
22.77B
Price / Sales (TTM)
‪16,675.17‬
Price / Book
‪9.68‬
EV / EBITDA
‪-72.67‬
Profitability
Profit Margin
‪74.49%‬
Operating Margin
‪-26,302.50%‬
Return on Assets
‪-7.46%‬
Return on Equity
‪-11.12%‬
Ownership
Shares Outstanding
214.01M
Float
143.56M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.01%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪114.67‬
200-Day Avg
‪56.45‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 6586 - Cho Pharma Inc.
Peers - 6586 - Cho Pharma Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 6586TWSECho Pharma Inc.24.18BMarket Cap+66.02%52-week change—P/E (Trailing)‪74.49%‬Profit Margin
- 6949TWSEPell Bio-Med Technology Co., Ltd.80.61BMarket Cap+68.42%52-week change-170.12P/E (Trailing)‪-13.97%‬Profit Margin
- 6696TWSELin BioScience, Inc.77.69BMarket Cap+83.89%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.22.82BMarket Cap-54.32%52-week change384.62P/E (Trailing)‪39.54%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.83BMarket Cap-2.00%52-week change30.17P/E (Trailing)‪35.54%‬Profit Margin
- 7827TWSEHanchorBio Inc.19.68BMarket Cap+42.27%52-week change—P/E (Trailing)‪-159.37%‬Profit Margin
Profile Summary - 6586 - Cho Pharma Inc.
About
Cho Pharma Inc. is a clinical-stage biotechnology company specializing in the development of innovative medicines using advanced glycoengineering technologies. Founded in 2012 and headquartered in Taipei, Cho Pharma focuses on creating next-generation therapeutic antibodies, vaccines, and antibody-drug conjugates by…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
